A Phase 1 clinical trial investigating a fixed-dose combination of CBD and hydroxychloroquine (IHL-675 A) for inflammatory conditions reports positive tol…

A Wilmington biotech firm is commencing a clinical trial for a synthetic CBD drug. Learn what this means for medicinal cannabis research, patient pathways…

A new clinical trial suggests CBD for hypertension may help reduce blood pressure in patients. Learn about the study published in the European Heart Journ…

An Italian medical cannabis trial has enrolled its first participant, investigating a cannabis-based medicine for ALS, Parkinson's, and Alzheimer's. Learn…

A new clinical trial is investigating the potential effects of cannabidiol (CBD) on liver enzyme levels. Learn why this research is crucial for understand…

A recent Phase 3 trial investigates a full-spectrum cannabis extract (VER-01) for chronic low back pain. Learn how this study suggests potential for pain…

Explore the emerging research on medicinal cannabis migraine benefits. Studies suggest cannabinoids may offer new avenues for managing this debilitating c…

To our readers and visitors, You may have noticed that things have been a bit quiet around here over the past week. It is with a heavy heart that we share the reason for this silence: our friend, colleague, and the editorial engine behind so much of what you read...

UK researchers have attempted to estimate risk thresholds for cannabis use disorder (CUD) based on delta-9-tetrahydrocannabinol (THC) consumption, using standard THC units.Cannabis use disorder is a condition whereby a person demonstrates a pattern of use that causes negative impacts in their life, but they continue to use it.The USA’s...

An Australian study looks at the impact of strict driving laws in that country on medical cannabis patients; and their attitudes towards/prevalence of driving under the influence.In most states in Australia, driving a vehicle while having any detectable level of THC in the bloodstream is illegal, regardless of lack...